The 'promises¿ and objectives of Tissue engineering proposed some 30 years ago have not delivered the numerous products and synthetic therapies for most of the tissue requirements of diseased or traumatised tissues. This may be due to the lack of standardisation during the induction, development, and maintenance of differentiation within cells and tissue matrices under in vitro conditions. This book brings together standard methods and protocols for these therapies with a view to bringing more products more speedily to the market. Chapters in the first part of the book discuss methods for standardising cell and tissue engineering applications whilst the final group of chapters discuss the protocols surrounding cell and tissue engineering.